Exhibit 99.1
| PRESS RELEASE |
Cyren Reports Second Quarter 2020 Financial Results
- - -
Positive initial market traction with new strategy and enterprise offerings
McLean, Va. – August 12, 2020 – Cyren (NASDAQ: CYRN), a provider of email security and threat intelligence solutions, today announced its second quarter 2020 financial results for the period ending June 30, 2020.
“During the second quarter Cyren continued to make good progress implementing our strategy. We achieved our key quarterly operational milestones, including completing the retooling of our U.S. salesforce, delivering two new enterprise products and closing our first customers for these new offerings” said Brett Jackson, Chief Executive Officer of Cyren. “With the key pieces of our foundational work behind us, we believe that we are positioned for bookings to accelerate in the second half as our new product sales execution matures and our first half pipeline building efforts begin to yield results”.
Second Quarter 2020 Financial Highlights:
| ● | Revenues for the second quarter of 2020 were $9.2 million, compared to $9.7 million during the second quarter of 2019. | |
| ● | GAAP
net loss for the second quarter of 2020 was $4.6 million, compared to a net loss of $4.6
million in the second quarter of 2019. | |
| ● | GAAP loss per basic and diluted share for the second quarter of 2020 was $0.08, compared to a loss of $0.08 per basic and diluted share for the second quarter of 2019. | |
| ● | Non-GAAP
net loss for the second quarter of 2020 was $3.8 million, compared to a Non-GAAP net
loss of $4.1 million for the second quarter of 2019. | |
| ● | Non-GAAP
loss per basic and diluted share was $0.06 for the Q2 2020, compared to a Non-GAAP loss
of $0.08 per share in Q2 2019. | |
| ● | Operating cash flow during the second quarter of 2020 was positive $2.5 million, compared to operating cash flow of positive $0.8 million during the second quarter of 2019. | |
| ● | Net cash flow for the second quarter of 2020 was positive $1.1 million, compared to negative $31 thousand during the second quarter of 2019. | |
| ● | Cash and cash equivalents balance as of June 30, 2020, was $16.1 million, compared to $11.6 million as of December 31, 2019. |
For information regarding the non-GAAP financial measures discussed in this release, please see “Use of Non-GAAP Financial Measures” and “Reconciliation of Selected GAAP Measures to Non-GAAP Measures.”
Recent Business Highlights:
| ● | In April, Cyren launched a new cloud-based anti-phishing product targeted at enterprise customers using Microsoft 365 (formerly Office 365) email. Cyren Inbox Security (CIS) is fully integrated within Microsoft 365 and provides continuous email monitoring and threat detection with automated response and remediation. |
| ● | Cyren recently announced positive early traction with Cyren Inbox Security and validating product market fit. In the first quarter of availability, Cyren converted several enterprise accounts and is protecting tens of thousands of Microsoft 365 mailboxes from phishing attacks, business email compromise (BEC) and fraudulent account takeovers. |
| ● | Also during the second quarter, Cyren launched Threat InDepth, a threat intelligence data product that provides detailed and actionable intelligence to enterprise security teams. Threat InDepth leverages Cyren’s GlobalView threat intelligence cloud, which analyzes billions of transactions daily to identify emerging security threats across email, web and files globally. Threat InDepth is the first product offering resulting from Cyren’s strategy to expand its core threat intelligence services beyond the OEM market into the larger enterprise market. |
| ● | In June, Cyren appointed a new Chairman of the Board, James Hamilton, who is an experienced security industry veteran. Mr. Hamilton was first appointed to the Cyren board of directors in 2012, and succeeds Lior Samuelson as Chairman. |
Financial
Results Conference Call:
The company will host a conference call at 10 a.m. Eastern Time (5 p.m. Israel Time) on Wednesday, August 12, 2020 to discuss second quarter results.
U.S.
Dial-in Number: 1-877-407-0312
Israel Dial-in Number: 1-80-940-6247
International Dial-in Number: 1-201-389-0899
The call will be simultaneously webcast live on the investor relations section of Cyren’s website at https://ir.cyren.com, or by using the following link: https://webcasts.eqs.com/cyren20200812/en.
For those unable to participate in the live conference call, a replay will be available until August 26, 2020. To access the replay, the U.S. dial in number is 1-877-660-6853 and the non-U.S. dial in number is 1-201-612-7415. Callers will be prompted for replay conference ID number 13707843. An archived version of the webcast will also be available on the investor relations section of the company’s website at https://ir.cyren.com/events.
2
About Cyren:
More than 1.3 billion users around the world rely on Cyren’s cloud security solutions to protect them against cyber attacks and data loss every day. Powered by GlobalView, Cyren’s global security cloud that identifies emerging threats on a global basis in real-time, Cyren (NASDAQ: CYRN) delivers fast time-to-protection with embedded threat detection services, threat intelligence and enterprise email security products for leading email providers, cybersecurity vendors, service providers and enterprises. Learn more at www.cyren.com.
Blog: http://blog.cyren.com
Facebook: www.facebook.com/CyrenWeb
LinkedIn: www.linkedin.com/company/cyren
Twitter: www.twitter.com/CyrenInc
Use
of Non-GAAP Financial Measures:
Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: stock-based compensation expenses, amortization of acquired intangible assets, and deferred taxes related to acquisitions, adjustments to earn-out obligations, and capitalization of technology. The purpose of such adjustments is to give an indication of the company’s performance exclusive of non-cash charges and other items that are considered by management to be outside of the company’s core operating results. The company’s non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read only in conjunction with the company’s consolidated financial statements prepared in accordance with GAAP.
Company management regularly uses supplemental non-GAAP financial measures internally to understand, manage and evaluate the business and make operating decisions.
These non-GAAP measures are among the primary factors management uses in planning for and forecasting future periods. The company believes this adjustment is useful to investors as a measure of the ongoing performance of the business. The company believes these non-GAAP financial measures provide consistent and comparable measures to help investors understand the company’s current and future operating cash flow performance. These non-GAAP financial measures may differ materially from the non-GAAP financial measures used by other companies. Reconciliation between results on a GAAP and non-GAAP basis is provided in a table immediately following the Consolidated Statements of Income. The presentation of this non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Management uses both GAAP and non-GAAP measures when evaluating the business internally and therefore felt it important to make these non-GAAP adjustments available to investors.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. For example, statements in the future tense, and statements including words such as “expect,” “plan,” “estimate,” “anticipate,” or “believe” are forward-looking statements. These statements are based on information available at the time of the press release and the company assumes no obligation to update any of them. The statements in this press release are not guarantees of future performance and actual results could differ materially from current expectations as a result of numerous factors, including business conditions and growth or deterioration in the internet security market, technological developments, products offered by competitors, availability of qualified staff, and technological difficulties and resource constraints encountered in developing new products, as well as those risks described in the company’s publicly filed reports, which are available through www.sec.gov.
Company
Contact
Mike Myshrall, CFO
Cyren
+1.703.760.3320
mike.myshrall@cyren.com
3
CYREN LTD.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands of U.S. dollars, except per share amounts)
| Three months ended | Six months ended | |||||||||||||||
| June 30 | June 30 | |||||||||||||||
| 2020 | 2019 | 2020 | 2019 | |||||||||||||
| Unaudited | Unaudited | Unaudited | Unaudited | |||||||||||||
| Revenues | $ | 9,181 | $ | 9,711 | $ | 18,830 | $ | 19,366 | ||||||||
| Cost of revenues | 3,778 | 3,789 | 7,376 | 7,789 | ||||||||||||
| Gross profit | 5,403 | 5,922 | 11,454 | 11,577 | ||||||||||||
| Operating expenses: | ||||||||||||||||
| Research and development, net | 4,151 | 4,297 | 7,495 | 8,474 | ||||||||||||
| Sales and marketing | 3,146 | 3,590 | 6,182 | 7,446 | ||||||||||||
| General and administrative | 2,476 | 2,398 | 4,690 | 4,830 | ||||||||||||
| Total operating expenses | 9,773 | 10,285 | 18,367 | 20,750 | ||||||||||||
| Operating loss | (4,370 | ) | (4,363 | ) | (6,913 | ) | (9,173 | ) | ||||||||
| Other income, net | 2 | 17 | 8 | 265 | ||||||||||||
| Financial expenses, net | (290 | ) | (268 | ) | (521 | ) | (321 | ) | ||||||||
| Loss before taxes | (4,658 | ) | (4,614 | ) | (7,426 | ) | (9,229 | ) | ||||||||
| Tax benefit | 44 | 41 | 61 | 80 | ||||||||||||
| Net loss | $ | (4,614 | ) | $ | (4,573 | ) | $ | (7,365 | ) | $ | (9,149 | ) | ||||
| Loss per share - basic and diluted | $ | (0.08 | ) | $ | (0.08 | ) | $ | (0.12 | ) | $ | (0.17 | ) | ||||
| Weighted average number of shares outstanding: | ||||||||||||||||
| Basic and Diluted | 60,041 | 54,424 | 59,862 | 54,300 | ||||||||||||
4
CYREN LTD.
RECONCILIATION OF SELECTED GAAP MEASURES TO NON-GAAP MEASURES
(in thousands of U.S. dollars, except per share amounts)
| Three months ended | Three months ended | |||||||||||||||
| June 30 | June 30 | |||||||||||||||
| 2020 | 2019 | 2020 | 2019 | |||||||||||||
| Unaudited | Unaudited | Unaudited | Unaudited | |||||||||||||
| GAAP gross profit | $ | 5,403 | $ | 5,922 | $ | 11,454 | $ | 11,577 | ||||||||
| GAAP gross margin | 59 | % | 61 | % | 61 | % | 60 | % | ||||||||
| Plus: | ||||||||||||||||
| Stock-based compensation expense | 20 | 33 | 64 | 62 | ||||||||||||
| Amortization of intangible assets | 593 | 767 | 1,024 | 1,606 | ||||||||||||
| Non-GAAP gross profit | 6,016 | 6,722 | 12,542 | 13,245 | ||||||||||||
| Non-GAAP gross margin | 66 | % | 69 | % | 67 | % | 68 | % | ||||||||
| GAAP operating loss | (4,370 | ) | (4,363 | ) | (6,913 | ) | (9,173 | ) | ||||||||
| Plus: | ||||||||||||||||
| Stock-based compensation expense | 507 | 314 | 1,152 | 583 | ||||||||||||
| Amortization of intangible assets | 723 | 885 | 1,283 | 1,851 | ||||||||||||
| Capitalization of technology | (389 | ) | 650 | ) | (1,602 | ) | (1,392 | ) | ||||||||
| Settlement of litigation, net | - | - | - | - | ||||||||||||
| Non-GAAP operating loss | (3,529 | ) | (3,814 | ) | (6,081 | ) | (8,131 | ) | ||||||||
| GAAP net loss | (4,614 | ) | (4,573 | ) | (7,365 | ) | (9,149 | ) | ||||||||
| Plus: | ||||||||||||||||
| Stock-based compensation expense | 507 | 314 | 1,152 | 583 | ||||||||||||
| Amortization of intangible assets | 723 | 885 | 1,283 | 1,851 | ||||||||||||
| Adjustment to earn-out liabilities | - | - | - | - | ||||||||||||
| Amortization of deferred tax assets | (48 | ) | (58 | ) | (96 | ) | (115 | ) | ||||||||
| Gain from an earn-out liability settlement | - | - | - | (256 | ) | |||||||||||
| Settlement of litigation, net | - | - | - | - | ||||||||||||
| Capitalization of technology | (414 | ) | (688 | ) | (1,657 | ) | (1,458 | ) | ||||||||
| Non-GAAP net loss | $ | (3,846 | ) | $ | (4,120 | ) | $ | (6,684 | ) | $ | (8,544 | ) | ||||
| Numerator for non-GAAP EPS calculation | $ | (3,846 | ) | $ | (4,120 | ) | $ | (6,684 | ) | $ | (8,544 | ) | ||||
| Non-GAAP net loss per share | $ | (0.06 | ) | $ | (0.08 | ) | $ | (0.11 | ) | $ | (0.16 | ) | ||||
| GAAP weighted-average shares used to | ||||||||||||||||
| compute net loss per share | 60,041 | 54,424 | 59,862 | 54,300 | ||||||||||||
5
CYREN LTD.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands of U.S. dollars)
| June 30 | December 31 | |||||||
| 2020 | 2019 | |||||||
| Unaudited | ||||||||
| Assets | ||||||||
| Current Assets: | ||||||||
| Cash and cash equivalents | $ | 16,103 | $ | 11,551 | ||||
| Trade receivables, net | 2,366 | 2,187 | ||||||
| Deferred commissions | 1,037 | 948 | ||||||
| Prepaid expenses and other receivables | 1,203 | 819 | ||||||
| Total current assets | 20,709 | 15,505 | ||||||
| Long-term deferred commissions | 1,352 | 1,580 | ||||||
| Long-term lease deposits | 850 | 767 | ||||||
| Operating lease right-of-use assets | 11,466 | 8,695 | ||||||
| Severance pay fund | 582 | 659 | ||||||
| Property and equipment, net | 4,675 | 4,410 | ||||||
| Intangible assets, net | 9,338 | 8,966 | ||||||
| Goodwill | 20,251 | 20,246 | ||||||
| Total long-term assets | 48,514 | 45,323 | ||||||
| Total assets | $ | 69,223 | $ | 60,828 | ||||
| Liabilities and Shareholders’ Equity | ||||||||
| Current Liabilities: | ||||||||
| Trade payables | $ | 1,106 | $ | 1,184 | ||||
| Employees and payroll accruals | 3,714 | 3,427 | ||||||
| Accrued expenses and other liabilities | 1,200 | 1,145 | ||||||
| Operating lease liabilities | 1,886 | 1,946 | ||||||
| Deferred revenues | 9,714 | 7,208 | ||||||
| Total current liabilities | 17,620 | 14,910 | ||||||
| Deferred revenues | 1,460 | 1,956 | ||||||
| Convertible notes | 10,000 | 10,000 | ||||||
| Convertible debentures | 9,447 | - | ||||||
| Long-term operating lease liabilities | 9,966 | 7,174 | ||||||
| Deferred tax liability | 677 | 796 | ||||||
| Accrued severance pay | 735 | 811 | ||||||
| Other liabilities | 633 | 470 | ||||||
| Total long-term liabilities | 32,918 | 21,207 | ||||||
| Shareholders’ equity | 18,685 | 24,711 | ||||||
| Total liabilities and shareholders’ equity | $ | 69,223 | $ | 60,828 | ||||
6
CYREN LTD.
CONDENSED CONSOLIDATED CASH FLOW DATA
(in thousands of U.S. dollars)
| Three months ended | Six months ended | |||||||||||||||
| June 30 | June 30 | |||||||||||||||
| 2020 | 2019 | 2020 | 2019 | |||||||||||||
| Cash flows from operating activities: | Unaudited | Unaudited | Unaudited | Unaudited | ||||||||||||
| Loss | $ | (4,614 | ) | $ | (4,573 | ) | (7,365 | ) | $ | (9,149 | ) | |||||
| Adjustments to reconcile loss to net cash provided by (used in) operating activities: | ||||||||||||||||
| Loss on disposal of property and equipment | 26 | - | 13 | 1 | ||||||||||||
| Depreciation | 597 | 475 | 1,215 | 936 | ||||||||||||
| Stock-based compensation | 507 | 314 | 1,152 | 583 | ||||||||||||
| Amortization of intangible assets | 723 | 885 | 1,283 | 1,851 | ||||||||||||
| Amortization of deferred commissions | 452 | (280 | ) | 803 | (612 | ) | ||||||||||
| Amortization of operating lease right-of-use assets | 534 | 362 | 922 | 713 | ||||||||||||
| Interest on convertible notes | 142 | 142 | 283 | 282 | ||||||||||||
| Interest and amortization of debt issuance costs on Convertible Debentures | 187 | - | 211 | - | ||||||||||||
| Other income related to the earn-out consideration | - | (1 | ) | - | (257 | ) | ||||||||||
| Deferred taxes, net | (54 | ) | (58 | ) | (118 | ) | (127 | ) | ||||||||
| Changes in assets and liabilities: | ||||||||||||||||
| Trade receivables | 490 | 27 | (162 | ) | 705 | |||||||||||
| Prepaid expenses and other receivables | (57 | ) | (37 | ) | (383 | ) | (775 | ) | ||||||||
| Deferred commissions | (276 | ) | 341 | (664 | ) | 748 | ||||||||||
| Change in long-term lease deposits | 28 | 3 | (86 | ) | 23 | |||||||||||
| Trade payables | (159 | ) | (418 | ) | (114 | ) | (823 | ) | ||||||||
| Employees and payroll accruals, accrued expenses and other liabilities | 444 | 50 | (47 | ) | (224 | ) | ||||||||||
| Deferred revenues | 4,062 | 3,891 | 1,989 | 6,354 | ||||||||||||
| Accrued severance pay, net | 24 | 27 | 1 | 68 | ||||||||||||
| Operating lease liabilities | (534 | ) | (368 | ) | (954 | ) | (733 | ) | ||||||||
| Other long-term liabilities | 10 | - | 163 | (111 | ) | |||||||||||
| Net cash provided by (used in) operating activities | 2,532 | 782 | (1,858 | ) | (547 | ) | ||||||||||
| Cash flows from investing activities: | ||||||||||||||||
| Proceeds from sale of property and equipment | 2 | - | 4 | - | ||||||||||||
| Capitalization of technology | (588 | ) | (808 | ) | (1,589 | ) | (1,435 | ) | ||||||||
| Purchase of property and equipment | (880 | ) | (406 | ) | (1,438 | ) | (950 | ) | ||||||||
| Net cash used in investing activities | (1,466 | ) | (1,214 | ) | (3,023 | ) | (2,385 | ) | ||||||||
| Cash flows from financing activities: | ||||||||||||||||
| Proceeds from convertible debenture, net of debt issuance costs | - | - | 9,442 | - | ||||||||||||
| Payment of earn-out consideration | - | - | - | (2,680 | ) | |||||||||||
| Proceeds from options exercised | - | 323 | - | 512 | ||||||||||||
| Net cash provided (used) by financing activities | - | 323 | 9,442 | (2,168 | ) | |||||||||||
| Effect of exchange rate changes on cash | (7 | ) | 78 | (13 | ) | (48 | ) | |||||||||
| Increase (decrease) in cash, cash equivalents and restricted cash | 1,059 | (31 | ) | 4,548 | (5,148 | ) | ||||||||||
| Cash, cash equivalents and restricted cash at the beginning of the period | 15,616 | 13,039 | 12,127 | 18,156 | ||||||||||||
| Cash, cash equivalents and restricted cash at the end of the period | $ | 16,675 | $ | 13,008 | $ | 16,675 | $ | 13,008 | ||||||||
| Reconciliation of cash, cash equivalents and restricted cash as shown in the consolidated statements of cash flow: | ||||||||||||||||
| Cash and cash equivalents | $ | 16,103 | $ | 12,405 | $ | 16,103 | $ | 12,405 | ||||||||
| Restricted cash included in long-term restricted lease deposits | 572 | 603 | 572 | 603 | ||||||||||||
| Total cash, cash equivalents and restricted cash | $ | 16,675 | $ | 13,008 | $ | 16,675 | $ | 13,008 | ||||||||
7